Investing Profile

Shawnalea Frazier

InvestorVC
Principal at Novo Holdings
novoholdings.dkSan Francisco, California
Photo of Shawnalea Frazier, Principal at Novo Holdings

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
3950 CONNECTIONS
Hotmail Network
3950 CONNECTIONS
Caltech Network
37 CONNECTIONS
AbbVie Network
13 CONNECTIONS
Novo Holdings Network
12 CONNECTIONS
Novo Holdings Principal
$100K - $5.0M
$1.5M
Senior Research Associate Circuit TherapeuticsPresent
Scientist Circuit TherapeuticsPresent
Executive Director of Business Development VxP Pharma and VxP Biologics, Inc.Present
Associate Novo HoldingsPresent
Board of Directors (Observer) Spruce BiosciencesPresent
Board of Directors (Observer) Avalyn PharmaPresent
Senior Associate Novo HoldingsPresent
Board of Directors (Observer) Praxis Precision Medicines, Inc.Present
Principal Novo HoldingsPresent
Corporate Strategy Consultant IgGenix, IncPresent
Director, West Coast Ventures AbbViePresent
Board of Directors (Observer) Trishula Therapeutics, Inc.Present
Board of Directors (Observer) Ribometrix Inc.Present
Board of Directors (Observer) Jnana TherapeuticsPresent
Board of Directors Nitrase TherapeuticsPresent
Board of Directors HotmailPresent
Co-Founder, Scientific Advisor HotmailPresent
Kansas State University Bachelor of Science (BS) & Master of Science (MS), 5-year accelerated program Biochemistry
Kansas State University Bachelor of Science (BS) & Master of Science (MS) 5-year accelerated program, Biochemistry
Caltech Doctor of Philosophy (PhD) Biochemistry and Molecular Biophysics, Neuroscience emphasis